BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.205
+0.035 (2.99%)
Jul 28, 2026, 4:59 PM CET
BioPorto Earnings Call Transcripts
Fiscal Year 2025
-
Kidney care is facing a global epidemic of AKI and CKD, with advances in biomarkers, AI, and pediatric devices improving early detection and outcomes. However, workforce shortages, resource constraints, and access disparities challenge care delivery, making interdisciplinary coordination and patient advocacy essential.
Fiscal Year 2024
-
A global commercial platform for early AKI detection is being built, focusing first on pediatric ICUs and expanding to adults and international markets. Sales momentum is strong, with key partnerships and clinician engagement driving adoption, and regulatory and reimbursement strategies are actively managed.